NCT00419640

SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation

Septal Pacing for Atrial Fibrillation Suppression Evaluation

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 385 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, parallel, single-blinded multi-center study. The objective is to compare the long term clinical outcomes among the site of atrial pacing and to compare the long term effect of the atrial fibrillation (AF) Suppression algorithm.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
DEVICE	Pacemaker implantation with RA lead in LAS position	Pacemaker implantation with RA lead placed in low atrial septal position
DEVICE	Pacemaker implantation with RA lead in LAS position	Pacemaker implantation with RA lead placed in low atrial septal position
DEVICE	Pacemaker implantation with RA lead in RAA position	Pacemaker implantation with RA lead placed in right atrial appendage position
DEVICE	Pacemaker implantation with RA lead in RAA position	Pacemaker implantation with RA lead placed in right atrial appendage position

Timeline

• Start date: 2005-05-01
• Primary completion: 2012-02-01
• Completion: 2012-11-01
• First posted: 2007-01-09
• Last updated: 2019-02-04

Locations

1 site across 1 country: Hong Kong